Product NDC: | 63739-251 |
Proprietary Name: | Valproic Acid |
Non Proprietary Name: | Valproic Acid |
Active Ingredient(s): | 250 mg/1 & nbsp; Valproic Acid |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, LIQUID FILLED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63739-251 |
Labeler Name: | McKesson Packaging Services Business Unit of McKesson Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA073229 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050301 |
Package NDC: | 63739-251-10 |
Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-251-10) > 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK |
NDC Code | 63739-251-10 |
Proprietary Name | Valproic Acid |
Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-251-10) > 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK |
Product NDC | 63739-251 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Valproic Acid |
Dosage Form Name | CAPSULE, LIQUID FILLED |
Route Name | ORAL |
Start Marketing Date | 20050301 |
Marketing Category Name | ANDA |
Labeler Name | McKesson Packaging Services Business Unit of McKesson Corporation |
Substance Name | VALPROIC ACID |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |